EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter

著者: Feng Shi, Min Zhou, Shang Li, Qianqian Du, Yueshuo Li, Longlong Xie, Xiaolan Liu, Min Tang, Xiangjian Luo, Jia Fan, Jian Zhou, Qiang Gao, Shuang–Jian Qiu, Wei‐Zhong Wu, Xin Zhang, Ann M. Bode, Ya Cao - Theranostics 2019 被引用: 56

: These results demonstrate a pathway by which EBV(LMP1)-associated metabolite changes inhibited necroptosis signaling by DNA methylation, and shed light on the mechanism underlying EBV-related carcinogenesis, which may provide new options for cancer diagnosis and therapy.